Retraction to: Oncogene https://doi.org/10.1038/s41388-024-03013-4, published online 28 March 2024
The Editors-in-Chief have retracted this article because of significant concerns regarding a number of figures presented in this work, which call into question the integrity of the data. After publication, partial overlap and high similarities between figures were detected. Specifically, between figure 2B Tubulin and figure 3A Tubulin, figure 5C 4-PBA and figure 6E sg_GSDMD, figure 5D NF-kB and figure 7E NK-kB, figure 5D Tubulin and figure 7E Tubulin, figure 8M sg_mGSDMD +SP23-CD8 and figure S7D Scramble-CD4.
The Editors-in-Chief therefore no longer have confidence in the integrity of the data in this article.
Author Shengpan Wu disagrees with this retraction. All other authors have not responded to correspondence from the publisher regarding this retraction.
Author information
Authors and Affiliations
Corresponding authors
About this article
Cite this article
Wu, S., Wang, B., Li, H. et al. Retraction Note: Targeting STING elicits GSDMD-dependent pyroptosis and boosts anti-tumor immunity in renal cell carcinoma. Oncogene 44, 3154 (2025). https://doi.org/10.1038/s41388-025-03526-6
Published:
Version of record:
Issue date:
DOI: https://doi.org/10.1038/s41388-025-03526-6
